To study effect of Ayurvedic medicines in Migraine

A randomized clinical trial on the comparative efficacy of Gandharyadi Ghrita Nasya and Dashmooladi Ghrita Nasya along with Dhatryadi Ghan Vati orally in Ardhavabhedaka with special reference to Migraine

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/05/042700

Enrollment

Registered

2022-05-20

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients willing to participate in this trial through written informed consent. 2.Both fresh and treated patients. 3.Patients between18 to 60 years of age from either sex. 4.Patients presenting with symptoms of Ardhavabhedaka vis-à-vis Migraine.

Exclusion criteria

Exclusion criteria: 1.Patients of age less than 18 and greater than 60 2.Patients with referred pain in one half of head due to other secondary reasons such as anxiety, refractive errors etc. rather than migraine. 3.Patients with complicated Migraine like hemiplegic migraine and having any chronic debilitating disease with other neurological pathology. 4.Pregnant and lactating women. 5.Patients suffering from any other major systemic disorders which interfare with course of treatment.

Design outcomes

Primary

Measure	Time frame
Decrease in intensity/ duration/ frequency of headache (MIDAS/ VAS) Timepoint: 30 days	—

Secondary

Measure	Time frame
Changes in other associated symptoms of migraine: 1.Nausea 2.Vomiting 3.Photophobia 4.Sleep disturbanceTimepoint: 31days	—

Countries

India

Contacts

Public ContactDr Mahima Choudhary

National Institute of Ayurveda (Deemed to be university) Jaipur.

appu07@gmail.com8955688129

Outcome results